Active substance(s): NOT APPLICABLE / NOT APPLICABLE / NOT APPLICABLE
NAME OF THE MEDICINAL PRODUCT
QUALITATIVE AND QUANTITATIVE COMPOSITION
Dry, chafed or irritated skin - Alcoderm is indicated in any condition where
the moisture content of the horny layer has decreased below the normal level
and the skin is no longer soft and pliable.
a) in acute inflammatory conditions where the skin is intact, such as sunburn
b) as a soothing, hydrating agent in certain inflammatory skin conditions
where there is dryness and scaling, such as ichthyosis, atopic eczema, winter
Posology and Method of Administration
Adults, children and the elderly
Apply topically to the skin as required to alleviate the symptoms of dry,
chafed or irritated skin conditions or as directed by a doctor.
Route of Administration:
Apply topically to the skin.
Hypersensitivity to the constituents of the preparation.
Special Warnings and Special Precautions for Use
Avoid contact with eyes.
If symptoms persist consult your physician.
In the rare event of a skin reaction, treatment should be discontinued.
Interactions with other Medicinal Products and other Forms of
Pregnancy and Lactation
May be used during this period.
Effects on Ability to Drive and Use Machines
Very rarely, a mild skin irritation can occur.
Accidental ingestion is not anticipated to cause any harm to the patient.
Pre-clinical Safety Data
Not relevant as the product has been in use for many years without apparent ill
List of Excipients
Mineral Oil (Liquid Paraffin)
Sodium Lauryl Sulphate Ph.
Methylparaben Ph. Eur.
Propylparaben Ph. Eur.
Cetyl Alcohol Ph. Eur.
Stearyl Alcohol Ph. Eur.
Sorbitan Monostearate Ph. Eur.
Perfume (Chemoderm 6435)
Purified Water Ph. Eur.
Special Precautions for Storage
Store at room temperature.
Nature and Content of Container
Polyethylene plastic cylindrical container with a polypropylene screw cap as
Package sizes: 120 ml, 200 ml.
Instruction for Use, Handling and Disposal
MARKETING AUTHORISATION HOLDER
Galderma (UK) Limited,
69-71 Clarendon Road
MARKETING AUTHORISATION NUMBER(S)
DATE OF FIRST AUTHORISATION/RENEWAL OF THE
21st January 1993
DATE OF REVISION OF THE TEXT
Source: Medicines and Healthcare Products Regulatory Agency
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.